Navigation
banner
Together we Drive the Future

Novel Protein Therapeutics

2017-02-212017-06-112017-05-11
EARLY BIRD DISCOUNT! Register by May 11, 2017 to receive 20% off your registration!
Or register 3 for the price of 2 with the coupon code rcdvb!


registration button

Antibody & Protein Therapeutics Summit


Antibodies in Oncology & Infectious Diseases

Antibody Drug Conjugates

Novel Protein Therapeutics
 
 

Dear Colleague,

GTCbio is proud to present the 5th Novel Protein Therapeutics Conference to be held on July 11-12, 2017 in Baltimore, MD. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development.

Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics including antibody drug conjugates, bispecific antibodies, antibody combinations, and check point inhibiting antibodies. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment!

Session Topics:

  1. Alternative Immunoglobulin Targeting Approaches in Protein Therapeutics
  2. Emerging & Novel Antigens in Diseases
  3. Advances in Antibody Engineering

We hope to see you there!

 

Best regards,

The 2017 Advisory Committee

 

2017 Program Director
Victor-Jeffrey Leyton, Université de Sherbrooke
2017 Advisory Board Members
Neeraj Agrawal, Amgen
Ahuva Nissim, Queen Mary University
Amandeep Gakhal, Sutro Biopharma
Ann White, University of Southampton
Bill Harriman , Crystal Bioscience
Birgit Schoeberl, Merrimack Pharmaceuticals
Elad Firnberg, Revolve Biotechnologies
Ernesto Freire, Johns Hopkins University
Nicolas Fischer, Novimmune SA
Gregory Adams, Eleven Biotherapeutics
Janos Luka, Walter Reed Army Institute of Research
Matthew Robinson, Immunome, Inc
Michael R. Dyson, IONTAS Ltd
Andreas Pahl, Heidelberg Pharma
Pedro Berraondo López, CIMA, University of Navarra
Darren Schofield, MedImmune
Seema Kumar, EMD Serono
Jamshid Tanha, University of Ottawa
Thomas Pillow, Genentech
Medha J. Tomlinson, Abbvie
Yan Chen, Genentech